Clinical trials
Infertility, Female trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 25 |
| 2018 | 11 |
| 2019 | 18 |
| 2020 | 17 |
| 2021 | 16 |
| 2022 | 16 |
| 2023 | 19 |
| 2024 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 152 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Third Hospital | 6 |
| Assiut University | 5 |
| Ain Shams Maternity Hospital | 4 |
| Riyadh Fertility and Reproductive Health center | 4 |
| Ain Shams University | 3 |
| Cairo University | 3 |
| Hillel Yaffe Medical Center | 3 |
| Instituto Valenciano de Infertilidad, IVI VALENCIA | 3 |
| Peter Humaidan | 3 |
| Reproductive & Genetic Hospital of CITIC-Xiangya | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility, Female | 152 |
| Infertility | 30 |
| Anxiety Disorders | 5 |
| Endometriosis | 4 |
| Infertility, Male | 4 |
| Polycystic Ovary Syndrome | 4 |
| Primary Ovarian Insufficiency | 4 |
| Ovarian Hyperstimulation Syndrome | 2 |
| Tuberculosis, Female Genital | 2 |
| Adenomyosis | 1 |
Trials
Showing 26 to 50 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.